154 related articles for article (PubMed ID: 29493726)
21. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
Graf P; Hallén H; Juto JE
Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
Karaki M; Akiyama K; Mori N
Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
[TBL] [Abstract][Full Text] [Related]
23. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
[TBL] [Abstract][Full Text] [Related]
25. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
Kubavat AH; Pawar P; Mittal R; Sinha V; Shah UB; Ojha T; Khippal N; Patel T
J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.
Baena-Cagnani CE; Patel P
Curr Med Res Opin; 2010 Sep; 26(9):2047-55. PubMed ID: 20629597
[TBL] [Abstract][Full Text] [Related]
27. Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey.
Ganesh V; Banigo A; McMurran AEL; Shakeel M; Ram B
J Laryngol Otol; 2017 Nov; 131(11):991-996. PubMed ID: 29050548
[TBL] [Abstract][Full Text] [Related]
28. [The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis].
Karpishchenko SA; Kolesnikova OM
Vestn Otorinolaringol; 2017; 82(5):44-47. PubMed ID: 29072663
[TBL] [Abstract][Full Text] [Related]
29. Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
Meltzer EO; Shekar T; Teper AA
Allergy Asthma Proc; 2011; 32(2):159-67. PubMed ID: 21439168
[TBL] [Abstract][Full Text] [Related]
30. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
Anolik R;
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
[TBL] [Abstract][Full Text] [Related]
31. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
Scadding GK
Clin Ther; 2000 Jul; 22(7):893-5. PubMed ID: 10945515
[No Abstract] [Full Text] [Related]
32. The effects of mometasone furoate and strontium chloride in a rat model of allergic rhinitis.
Altuntaş EE; Doğan ÖT; Saraç B; Turgut NH; Durmuş K; Akyol M
Ear Nose Throat J; 2018; 97(1-2):E1-E7. PubMed ID: 29493722
[TBL] [Abstract][Full Text] [Related]
33. Ciliary beat frequency of in vitro human nasal epithelium measured with the simple high-speed microscopy is applicable for safety studies of nasal drug formulations.
Tratnjek L; Kreft M; Kristan K; Kreft ME
Toxicol In Vitro; 2020 Aug; 66():104865. PubMed ID: 32311434
[TBL] [Abstract][Full Text] [Related]
34. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy.
Ras AE; Hamed MH; Abdelalim AA
Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830
[TBL] [Abstract][Full Text] [Related]
35. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.
Prenner BM; Lanier BQ; Bernstein DI; Shekar T; Teper A
J Allergy Clin Immunol; 2010 Jun; 125(6):1247-1253.e5. PubMed ID: 20434199
[TBL] [Abstract][Full Text] [Related]
36. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma.
Bennett ML; Fountain JM; McCarty MA; Sherertz EF
Am J Contact Dermat; 2001 Dec; 12(4):193-6. PubMed ID: 11753891
[TBL] [Abstract][Full Text] [Related]
37. Effects of topical sprays on allergy-induced nasal obstruction in children.
Yaşar M; Uysal IÖ; Altuntaş EE; Cevit Ö; Müderris S
Kulak Burun Bogaz Ihtis Derg; 2013; 23(4):217-24. PubMed ID: 23834132
[TBL] [Abstract][Full Text] [Related]
38. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
39. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
Emanuel IA; Blaiss MS; Meltzer EO; Evans P; Connor A
Am J Rhinol Allergy; 2014; 28(2):117-21. PubMed ID: 24598007
[TBL] [Abstract][Full Text] [Related]
40. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial.
Khan MA; Abou-Halawa AS; Al-Robaee AA; Alzolibani AA; Al-Shobaili HA
J Laryngol Otol; 2010 Apr; 124(4):397-401. PubMed ID: 19930776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
